# Spero Therapeutics, Inc.: Form 8-K, filed Feb 28, 2020

- Company: [Spero Therapeutics, Inc.](/companies/spro.md) (CIK 1701108)
- Form: 8-K
- Filed: 2020-02-28
- Accepted by EDGAR: Feb 28, 2020, 16:31 ET
- Period: 2020-02-28
- Accession: 0001193125-20-056529
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1701108/000119312520056529/d871925d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1701108/000119312520056529/

## Items reported

- Item 3.03: Change to security holders’ rights
- Item 5.03: Amendment to articles or bylaws
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1701108/000119312520056529/d871925d8k.htm

Filed Feb 28, 2020.
Source: SEC EDGAR, the filing index for accession 0001193125-20-056529. Last ingested by Listed: Nov 13, 2026, 16:27 ET. No prices; not investment advice.
